Madrigal Pharmaceuticals Inc
NASDAQ:MDGL

Watchlist Manager
Madrigal Pharmaceuticals Inc Logo
Madrigal Pharmaceuticals Inc
NASDAQ:MDGL
Watchlist
Price: 593.8 USD -0.85%
Market Cap: 13.5B USD

Wall Street
Price Targets

MDGL Price Targets Summary
Madrigal Pharmaceuticals Inc

Wall Street analysts forecast MDGL stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MDGL is 611.04 USD with a low forecast of 507.02 USD and a high forecast of 945 USD.

Lowest
Price Target
507.02 USD
15% Downside
Average
Price Target
611.04 USD
3% Upside
Highest
Price Target
945 USD
59% Upside
Madrigal Pharmaceuticals Inc Competitors:
Price Targets
DVAX
Dynavax Technologies Corp
38% Upside
ACAD
ACADIA Pharmaceuticals Inc
8% Upside
BVXP
Bioventix PLC
121% Upside
SERA
Sera Prognostics Inc
45% Upside
603087
Gan & Lee Pharmaceuticals
1% Downside
ORGO
Organogenesis Holdings Inc
64% Upside
ASMB
Assembly Biosciences Inc
45% Upside
ABNX
Abionyx Pharma SA
213% Upside

Revenue
Forecast

Revenue Estimate
Madrigal Pharmaceuticals Inc

For the last 13 years the compound annual growth rate for Madrigal Pharmaceuticals Inc's revenue is 28%. The projected CAGR for the next 4 years is 102%.

28%
Past Growth
102%
Estimated Growth
Estimates Accuracy
2%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Madrigal Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Net Income
Forecast

Net Income Estimate
Madrigal Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-42%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is MDGL's stock price target?
Price Target
611.04 USD

According to Wall Street analysts, the average 1-year price target for MDGL is 611.04 USD with a low forecast of 507.02 USD and a high forecast of 945 USD.

What is Madrigal Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
102%

For the last 13 years the compound annual growth rate for Madrigal Pharmaceuticals Inc's revenue is 28%. The projected CAGR for the next 4 years is 102%.

Back to Top